Cano Health, Inc. (CANO) has a consensus analyst rating of Hold, based on 10 analysts covering the stock. Of those, 0 recommend buying, 8 recommend holding, and 2 recommend selling.
The analyst consensus price target for CANO is $402.33, representing a +17,392.6% upside from the current price of $2.3. Price targets range from a low of $125.00 to a high of $832.00.
